GTS Securities’s Neuphoria Therapeutics NEUP Stock Holding History
Bought
Maintained
Sold
Other funds holding NEUP
LCM
GTS Securities's NEUP Position: Q3 2026 in Review
GTS Securities opened a new position in Neuphoria Therapeutics (NEUP) in Q3 2026: 11,487 shares worth $40.9K. The stake represents ﹤0.01% of the portfolio and ranks #1645 among its holdings.
19 funds tracked by Wall St. Rank hold NEUP as of Q3 2026.
- GTS Securities held 11,487 shares of Neuphoria Therapeutics worth $40.9K as of Q3 2026.
- Neuphoria Therapeutics was a new GTS Securities position in Q3 2026.
- Neuphoria Therapeutics made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1645 holding.
- 19 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.